Abstract |
These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In addition, information is included regarding the use of chemoprophylaxis against B. anthracis.
|
Authors | |
Journal | Journal of toxicology. Clinical toxicology
(J Toxicol Clin Toxicol)
Vol. 39
Issue 1
Pg. 85-100
( 2001)
ISSN: 0731-3810 [Print] United States |
PMID | 11327233
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Adult
- Animals
- Anthrax
(immunology, prevention & control)
- Anthrax Vaccines
(administration & dosage, adverse effects, therapeutic use)
- Bacillus anthracis
- Child
- Humans
- Immunity, Cellular
- Injections, Intramuscular
- Injections, Subcutaneous
- United States
|